
FDA approved a new rizatriptan orally disintegrating film, Rizafilm.
FDA approves Rizafilm, the first oral thin film using IntelGenx proprietary drug delivery technology, for the acute treatment of migraine with or without aura.
FDA has cleared a new preventive treatment for migraine! This treatment is called Nerivio, a wearable, drug-free treatment that activates peripheral nerves by remote electrical modulation. Treatment with Nerivio is 45 minutes, the device is worn on the upper arm, and controlled by an app on a smartphone. In clinical studies a mean reduction of 4 migraine days per month was observed among participants using Nerivio every other day. Nerivio has already proven efficacy in acute migraine treatment but is now also cleared for preventive treatment of migraine. To learn more follow the link below.